Amerikanische Gesellschaft für Hirudotherapie

Genetic barcoding of marine leeches (Ozobranchus spp.) from Florida sea turtles and their divergence in host specificity

DNA barcoding study published in Molecular Ecology Resources (2010)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Genomik & ProteomikSicherheit & InfektionskontrolleMcGowin AE et al. · Molecular ecology resources, 2010

Abstract

Ozobranchus margoi and Ozobranchus branchiatus are the only two species of marine turtle leeches (Ozobranchus spp.) known to inhabit the Atlantic coast of the United States and the Gulf of Mexico. In early reports of fibropapillomatosis (FP) in green turtles (Chelonia mydas), O. branchiatus was implicated as a vector in the transmission of Fibropapilloma-associated turtle herpesvirus (FPTHV). It is imperative that the leech species be identified to elucidate the role Ozobranchus spp. may play in disease transmission. In this study, Ozobranchus branchiatus has been identified for the first time on a loggerhead (Caretta caretta) turtle, and the molecular data for this species is now available for the first time in GenBank. Both species of leeches were also found infecting a single C. mydas. Using morphological taxonomy combined with distance- and character-based genetic sequence analyses, this study has established a DNA barcode for both species of Ozobranchus spp. leech and has shown it can be applied successfully to the identification of leeches at earlier stages of development when morphological taxonomy cannot be employed. The results suggest a different haplotype may exist for O. branchiatus leeches found on C. caretta versus C. mydas. Leech cocoon residue collected from a C. mydas was identified using the new method.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeEvaluation StudyJournal Article
Indexed MeSH termsAnimalsBase SequenceDNA Barcoding, TaxonomicEvolution, MolecularFloridaHost SpecificityLeechesMolecular Sequence DataPhylogenyTurtles

Zusammenfassung

DNA barcoding of marine turtle leeches Ozobranchus margoi and O. branchiatus reveals host-specific haplotypes; implicates these leeches as vectors of fibropapilloma-associated herpesvirus.

Warum dies für die Hirudotherapie relevant ist

This study established DNA barcodes for two marine turtle leech species, Ozobranchus margoi and O. branchiatus, using morphological taxonomy combined with distance- and character-based genetic sequence analyses. The authors report the first record of O. branchiatus on a loggerhead turtle (Caretta caretta), document both species co-infecting a single green turtle, suggest a possible haplotype difference between O. branchiatus from different turtle hosts, and note the relevance to investigating these leeches as potential vectors of Fibropapilloma-associated turtle herpesvirus. The study is taxonomic and disease-ecological in nature, involving marine ectoparasitic leeches with no connection to medicinal leech use, hirudotherapy, or the therapeutic leech secretome. Its relevance to ASH's domain is negligible beyond illustrating diversity within the broader leech clade.

Zitation

Genetic barcoding of marine leeches (Ozobranchus spp.) from Florida sea turtles and their divergence in host specificity.

McGowin AE et al. · Molecular ecology resources, 2010

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.